Exenatide
ECHO
AstraZeneca · Phase 3 · Completed · Enrollment 42
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- Exenatide once weekly extended-release: week 36 1.7%
- Matching placebo: week 36 3.5%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.